Hexagon Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-69	Closed	-$33.5K	–	1681
2025 Q1	$33.5K	Sell	69 -4	-5%	-$1.86K	0.01%	586
2024 Q4	$29.4K	Sell	73 -50	-41%	-$23.2K	0.01%	649
2024 Q3	$57.2K	Sell	123 -13	-10%	-$6.25K	0.01%	424
2024 Q2	$63.7K	Sell	136 -2	-1%	-$868	0.01%	380
2024 Q1	$57.7K	Buy	138 +59	+75%	+$24.9K	0.01%	399
2023 Q4	$32.1K	Buy	79 +2	+3%	+$739	0.01%	516
2023 Q3	$26.8K	Hold	77	–	–	0.01%	488
2023 Q2	$27.1K	Hold	77	–	–	0.01%	484
2023 Q1	$24.3K	Hold	77	–	–	0.01%	500
2022 Q4	$22.2K	Sell	77 -63	-45%	-$19.2K	0.01%	517
2022 Q3	$41K	Hold	140	–	–	0.01%	429
2022 Q2	$39K	Hold	140	–	–	0.01%	417
2022 Q1	$37K	Hold	140	–	–	0.01%	410
2021 Q4	$31K	Hold	140	–	–	0.01%	431
2021 Q3	$25K	Sell	140 -87	-38%	-$17K	0.01%	455
2021 Q2	$46K	Buy	227 +8	+4%	+$1.67K	0.01%	341
2021 Q1	$47K	Hold	219	–	–	0.01%	317
2020 Q4	$51K	Hold	219	–	–	0.02%	267
2020 Q3	$45K	Buy	+219	New	+$60.4K	0.01%	267